About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Lymphoma Survival Could Be Improved By An Immune-Boosting Antibody Combination

by Aishwarya Radhakrishnan on December 2, 2017 at 12:09 AM
Font : A-A+

Lymphoma Survival Could Be Improved By An Immune-Boosting Antibody Combination

According to a Cancer Research UK funded study published in Cancer Cell,combining two different immunotherapy treatments could dramatically improve lymphoma survival.

Researchers from the University of Southampton tested different combinations of antibodies in the lab to see how they interact with each other and what effect this has on how the immune system fights cancer.

Advertisement


They found one combination - anti-CD27 and anti-CD20 - greatly increased life expectancy in mice with cancer. While most of the mice given just one of the antibodies died within 80 days, nearly all mice given both antibodies survived beyond 100 days.

As a direct result of this study, the combination will now be tested in patients as part of a clinical trial funded by Cancer Research UK.

Dr Sean Lim, a Cancer Research UK clinician scientist at the University of Southampton, said: "By combining two specific antibodies - anti-CD27 and anti-CD20 - we've increased the ability of the immune system to destroy cancer cells.
Advertisement

"It's very exciting to see that this drug combination has an impact on survival of mice with lymphoma, as improvements in treatment are urgently needed. The next stage will be to see if what we've discovered can be replicated in patients."

Professor Karen Vousden, Cancer Research UK's chief scientist, said: "This study greatly increases our understanding of how different immunotherapies can work together to improve the way we treat lymphoma.

"By testing this approach in a clinical trial we will see if this promising research will translate into benefit for patients."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chronic Lymphocytic Leukemia AIDS-HIV-Cancer Anal Warts Bone Marrow Transplantation 

Recommended Reading
Follicular Lymphoma
Follicular lymphoma is a slow growing cancer of the lymph nodes. It is the most common form of slow ...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by ....
AIDS-HIV-Cancer
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity....
Chemotherapy Drugs
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body....
Anal Warts
Anal warts or genital warts are soft bumps caused by Human Papilloma Virus and are a sexually transm...
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use